Slomovitz BM - Search Results

1

Association between adiponectin, insulin resistance, and endometrial cancer.

Soliman PT, Wu D, Tortolero-Luna G, Schmeler KM, Slomovitz BM, Bray MS, Gershenson DM, Lu KH. Soliman PT, et al. Among authors: slomovitz bm. Cancer. 2006 Jun 1;106(11):2376-81. doi: 10.1002/cncr.21866. Cancer. 2006. PMID: 16639730 Free article.

2

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer.

Mirza MR, Monk BJ, Herrstedt J, Oza AM, Mahner S, Redondo A, Fabbro M, Ledermann JA, Lorusso D, Vergote I, Ben-Baruch NE, Marth C, Mądry R, Christensen RD, Berek JS, Dørum A, Tinker AV, du Bois A, González-Martín A, Follana P, Benigno B, Rosenberg P, Gilbert L, Rimel BJ, Buscema J, Balser JP, Agarwal S, Matulonis UA; ENGOT-OV16/NOVA Investigators. Mirza MR, et al. N Engl J Med. 2016 Dec 1;375(22):2154-2164. doi: 10.1056/NEJMoa1611310. Epub 2016 Oct 7. N Engl J Med. 2016. PMID: 27717299 Free article. Clinical Trial.

3

Coordinate expression of Cdc25B and ER-alpha is frequent in low-grade endometrioid endometrial carcinoma but uncommon in high-grade endometrioid and nonendometrioid carcinomas.

Wu W, Slomovitz BM, Celestino J, Chung L, Thornton A, Lu KH. Wu W, et al. Among authors: slomovitz bm. Cancer Res. 2003 Oct 1;63(19):6195-9. Cancer Res. 2003. PMID: 14559803

4

Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases.

Slomovitz BM, Burke TW, Eifel PJ, Ramondetta LM, Silva EG, Jhingran A, Oh JC, Atkinson EN, Broaddus RR, Gershenson DM, Lu KH. Slomovitz BM, et al. Gynecol Oncol. 2003 Dec;91(3):463-9. doi: 10.1016/j.ygyno.2003.08.018. Gynecol Oncol. 2003. PMID: 14675663 Review.

5

Commenting on "HER2/neu overexpression: has the Achilles' heel of uterine serous papillary carcinoma been exposed? (88:263-5) by Santin AD".

Slomovitz BM, Lu KH. Slomovitz BM, et al. Gynecol Oncol. 2004 Jan;92(1):386-7; author reply 387. doi: 10.1016/j.ygyno.2003.10.013. Gynecol Oncol. 2004. PMID: 14751194 No abstract available.

6

Her-2/neu overexpression and amplification in uterine papillary serous carcinoma.

Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Wu W, Sun CC, Munsell MF, Gershenson DM, Lu KH. Slomovitz BM, et al. J Clin Oncol. 2004 Aug 1;22(15):3126-32. doi: 10.1200/JCO.2004.11.154. J Clin Oncol. 2004. PMID: 15284264

7

Does tamoxifen use affect prognosis in breast cancer patients who develop endometrial cancer?

Slomovitz BM, Sun CC, Ramirez PT, Bodurka DC, Diaz P, Lu KH. Slomovitz BM, et al. Obstet Gynecol. 2004 Aug;104(2):255-60. doi: 10.1097/01.AOG.0000131620.67911.03. Obstet Gynecol. 2004. PMID: 15291996

8

Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases.

Soliman PT, Slomovitz BM, Broaddus RR, Sun CC, Oh JC, Eifel PJ, Gershenson DM, Lu KH. Soliman PT, et al. Among authors: slomovitz bm. Gynecol Oncol. 2004 Aug;94(2):456-62. doi: 10.1016/j.ygyno.2004.05.006. Gynecol Oncol. 2004. PMID: 15297188 Review.

9

Expression of imatinib mesylate-targeted kinases in endometrial carcinoma.

Slomovitz BM, Broaddus RR, Schmandt R, Wu W, Oh JC, Ramondetta LM, Burke TW, Gershenson DM, Lu KH. Slomovitz BM, et al. Gynecol Oncol. 2004 Oct;95(1):32-6. doi: 10.1016/j.ygyno.2004.06.052. Gynecol Oncol. 2004. PMID: 15385107

10

Risk factors for young premenopausal women with endometrial cancer.

Soliman PT, Oh JC, Schmeler KM, Sun CC, Slomovitz BM, Gershenson DM, Burke TW, Lu KH. Soliman PT, et al. Among authors: slomovitz bm. Obstet Gynecol. 2005 Mar;105(3):575-80. doi: 10.1097/01.AOG.0000154151.14516.f7. Obstet Gynecol. 2005. PMID: 15738027

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

143 results

Search Page

Filters